发明名称 HBV polymerase mutants
摘要 The present invention relates to polymerase HBV mutant polypeptides comprising a mutated polymerase domain which is functionally disrupted for polymerase activity and fusion proteins comprising such polymerase mutant polypeptide. The present invention also relates to a nucleic acid molecule and an expression vector for expressing said polymerase mutant polypeptide as well as a composition which can be used for eliciting an immune response to HBV with the goal of providing a protective or therapeutic effect against HBV infection.
申请公布号 AU2012282506(B2) 申请公布日期 2017.03.16
申请号 AU20120282506 申请日期 2012.07.12
申请人 Transgene SA 发明人 Martin, Perrine;Silvestre, Nathalie;Marchand, Jean-Baptiste
分类号 C12N9/22;A61K38/16;A61K39/29;A61P31/12;C07K14/02;C12N5/10 主分类号 C12N9/22
代理机构 代理人
主权项
地址